1. Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells
   EDUARDO PARRA, 2012, International Journal of Molecular Medicine CrossRef
2. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells
   EDUARDO PARRA et al, 2015, Oncology Reports CrossRef
3. The role of tumor suppressor short non-coding RNAs on breast cancer
   Shokooh Salimimoghadam et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
4. Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer
   B Turner-Ivey et al, 2013, Oncogene CrossRef
5. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches
   Rachel A. Wood et al, 2018, Pharmacology Research & Perspectives CrossRef
6. Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA
   EDUARDO PARRA et al, 2013, Oncology Reports CrossRef
7. PLGA nanomedical consignation: A novel approach for the management of prostate cancer
   Tenzin Sonam Dongsar et al, 2024, International Journal of Pharmaceutics CrossRef
8. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
   B Colleoni et al, 2017, Oncogene CrossRef
9. Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor
   EDUARDO PARRA et al, 2013, Oncology Reports CrossRef